Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
Trial record 1 of 2 for:    nct01461837
Previous Study | Return to List | Next Study

Haplo T-Cell Depleted Transplantation in High-Risk Sickle Cell Disease (HaploSCD)

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2017 by New York Medical College
Sponsor:
Collaborators:
Children's Hospital & Research Center Oakland
Medical College of Wisconsin
Washington University School of Medicine
Tufts Medical Center
University of California, San Francisco
University of California, Los Angeles
Miltenyi Biotec GmbH
Ann and Robert H. Lurie Children's Hospital of Chicago
Information provided by (Responsible Party):
Mitchell Cairo, New York Medical College
ClinicalTrials.gov Identifier:
NCT01461837
First received: October 19, 2011
Last updated: May 5, 2017
Last verified: May 2017
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: April 2019
  Estimated Primary Completion Date: April 2018 (Final data collection date for primary outcome measure)